gdc

Conference Correspondent

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
A phase 2 trial of Enhertu (trastuzumab deruxtecan) in patients with HER2-positive metastatic breast cancer show high rates of positive results in patients who have been heavily pretreated. These results are preliminary and encouraging.
SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
Breast cancer and its treatment impacts sexual health, which is an important topic for patients and clinicians to be able to address throughout the treatment process.
SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
The DESTINY-Breast05 trial will help researchers understand the potential benefit of Enhertu (trastuzumab deruxtecan), a powerful potential treatment of patients with breast cancer with residual invasive disease after receiving chemotherapy.
SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
Panelists discuss the challenges of the pandemic and its impact on the risk for pandemic-related disruptions in cancer care, breast cancer diagnosis, timing and choice of treatment, and mental health.
SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
Minority women need timely, high-quality access to care, as delays in diagnosis and treatment may be fatal. Patients and clinicians need to work together to overcome obstacles, so they can gain access to the best screening, genetic testing, and treatments through clinical trials.
SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
In patients with HER2-expressing metastatic breast cancer, Enhertu (trastuzumab deruxtecan) plus Opdivo (nivolumab) demonstrated antitumor activity consistent with previous studies of Enhertu and had an acceptable safety profile in this short-term analysis.
SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
For patients with breast cancer, adhering to a diabetes risk reduction diet improved survival when compared with patients who did not follow this diet.
SABCS 2020 Wrap-Up
Conference Correspondent – December 16, 2020
To reduce depressive symptoms, behavioral intervention techniques of mindfulness mediation and survivorship education are helpful, according to results from a recent randomized, controlled clinical trial.
SABCS 2020 Wrap-Up
Conference Correspondent – December 14, 2020
Sharon Gentry, a Breast Cancer Nurse Navigator in Winston-Salem, NC, shares how the San Antonio Breast Cancer Symposium contributes to better care for patients with breast cancer.
SABCS 2020 Wrap-Up
Conference Correspondent – December 14, 2020
Sharon Gentry, a Breast Cancer Nurse Navigator in Winston-Salem, NC, discusses the importance of ENHERTU to patients with HER2-positive breast cancer.
Page 1 of 7
Results 1 - 10 of 64

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country